Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Crossref DOI link: https://doi.org/10.1186/s12885-016-2491-y
Published Online: 2016-07-13
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kasi, Pashtoon M.
Kotani, Daisuke
Cecchini, Michael
Shitara, Kohei
Ohtsu, Atsushi
Ramanathan, Ramesh K.
Hochster, Howard S.
Grothey, Axel
Yoshino, Takayuki
License valid from 2016-07-13